China: Use of angiotensin receptor–neprilysin inhibitors (ARNIs) in lung cancer patients with hypertension receiving immune ...

Angiotensin II receptor antagonists are agents used to modify the renin-angiotensin-aldosterone system (RAAS) through blocking angiotensin receptors. This has the effect of lowering blood pressure.

Discover how a traditional Chinese herbal mix showed better results in treating a common kidney disease compared to commonly ...

The renin-angiotensin-aldosterone system (RAAS), or renin-angiotensin-system (RAS) is a regulator of blood pressure and cardiovascular function. Dysregulated RAAS is implicated in high blood pressure, ...

Among four classes of blood pressure medication, angiotensin receptor blockers (ARBs) had the highest medication persistence, meaning patients taking the drugs were most likely to stay on them. This ...

Angiotensin-converting enzyme (ACE) expression by myeloid cells is increased in response to infection. Forced ACE overexpression in mouse macrophages increases their ability to respond to infection ...

A personalized alert tool improve use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for ...

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

We compared the angiotensin receptor–neprilysin inhibitor LCZ696 with enalapril in patients who had heart failure with a reduced ejection fraction. In previous studies, enalapril improved survival in ...

Angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers are used commonly in clinical practice to treat hypertension and decrease cardiovascular events in high-risk patients.

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease ...